The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups

Frank N M Twisk, Frank N M Twisk

Abstract

Although Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) are used interchangeably, the diagnostic criteria define two distinct clinical entities. Cognitive impairment, (muscle) weakness, circulatory disturbances, marked variability of symptoms, and, above all, post-exertional malaise: a long-lasting increase of symptoms after a minor exertion, are distinctive symptoms of ME. This latter phenomenon separates ME, a neuro-immune illness, from chronic fatigue (syndrome), other disorders and deconditioning. The introduction of the label, but more importantly the diagnostic criteria for CFS have generated much confusion, mostly because chronic fatigue is a subjective and ambiguous notion. CFS was redefined in 1994 into unexplained (persistent or relapsing) chronic fatigue, accompanied by at least four out of eight symptoms, e.g., headaches and unrefreshing sleep. Most of the research into ME and/or CFS in the last decades was based upon the multivalent CFS criteria, which define a heterogeneous patient group. Due to the fact that fatigue and other symptoms are non-discriminative, subjective experiences, research has been hampered. Various authors have questioned the physiological nature of the symptoms and qualified ME/CFS as somatization. However, various typical symptoms can be assessed objectively using standardized methods. Despite subjective and unclear criteria and measures, research has observed specific abnormalities in ME/CFS repetitively, e.g., immunological abnormalities, oxidative and nitrosative stress, neurological anomalies, circulatory deficits and mitochondrial dysfunction. However, to improve future research standards and patient care, it is crucial that patients with post-exertional malaise (ME) and patients without this odd phenomenon are acknowledged as separate clinical entities that the diagnosis of ME and CFS in research and clinical practice is based upon accurate criteria and an objective assessment of characteristic symptoms, as much as possible that well-defined clinical and biological subgroups of ME and CFS patients are investigated in more detail, and that patients are monitored before, during and after interventions with objective measures and biomarkers.

Keywords: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis; assessment; diagnosis; immune system; post-exertional malaise; subgroups.

References

    1. (1978). Epidemic myalgic encephalomyelitis. Br. Med. J. 1, 1436–1437 10.1136/bmj.1.2791.1436-a
    1. Aschbacher K., Adam E. K., Crofford L. J., Kemeny M. E., Demitrack M. A., Ben-Zvi A. (2012). Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study. Brain Behav. Immun. 26, 1047–1056 10.1016/j.bbi.2012.06.002
    1. American College of ardiology, Benditt D. G., Ferguson D. W., Grubb B. P., Kapoor W. N., Kugler J., et al. (1996). Tilt table testing for assessing syncope. J. Am. Coll. Cardiol. 28, 263–275 10.1016/0735-1097(96)00236-7
    1. American College of Sports Medicine. (2009). ACSM's Guidelines for Exercise Testing and Prescription, 8th Edn. Ambler, PA: Lippincott Williams and Wilkins
    1. Acheson E. D. (1959). The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am. J. Med. 26, 569–595 10.1016/0002-9343(59)90280-3
    1. Amann M., Subudhi A. W., Walker J., Eisenman P., Shultz B., Foster C. (2004). An evaluation of the predictive validity and reliability of ventilatory threshold. Med. Sci. Sports Exerc. 36, 1716–1722 10.1249/01.MSS.0000142305.18543.34
    1. Andrews A. W., Thomas M. W., Bohannon R. W. (1996). Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys. Ther. 76, 248–259
    1. Badham S. P., Hutchinson C. V. (2013). Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 251, 2769–2776 10.1007/s00417-013-2431-3
    1. Balady G. J., Arena R., Sietsema K., Myers J., Coke L., Fletcher G. F., et al. (2010). Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 122, 191–225 10.1161/CIR.0b013e3181e52e69
    1. Ball K., Owsley C. (1993). The useful field of view test: a new technique for evaluating age-related declines in visual function. J. Am. Optom. Assoc. 64, 71–79
    1. Ball K., Owsley C., Sloane M. E., Roenker D. L., Bruni J. R. (1993). Visual attention problems as a predictor of vehicle crashes in older drivers. Invest. Ophthalmol. Vis. Sci. 34, 3110–3123
    1. Baraniuk J. N., Casado B., Maibach H., Clauw D. J., Pannell L. K., Hess S. S. (2005). A chronic fatigue syndrome - related proteome in human cerebrospinal fluid. BMC Neurol. 5:22 10.1186/1471-2377-5-22
    1. Barsky A. J., Borus J. F. (1999). Functional somatic syndromes. Ann. Intern. Med. 130, 910–921 10.7326/0003-4819-130-11-199906010-00016
    1. Behan W. M., More I. A., Behan P. O. (1991). Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 83, 61–65 10.1007/BF00294431
    1. Bensimhon D. R., Leifer E. S., Ellis S. J., Fleg J. L., Keteyian S. J., Piña I. L., et al. (2008). Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am. J. Cardiol. 102, 712–717 10.1016/j.amjcard.2008.04.047
    1. Bergersen L. H., Gjedde A. (2012). Is lactate a volume transmitter of metabolic states of the brain? Front. Neuroenergetics 4:5 10.3389/fnene.2012.00005
    1. Biswal B., Kunwar P., Natelson B. H. (2011). Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J. Neurol. Sci. 301, 9–11 10.1016/j.jns.2010.11.018
    1. Bloomer R. J., Goldfarb A. H., Wideman L., McKenzie M. J., Consitt L. A. (2005). Effects of acute aerobic and anaerobic exercise on blood markers of oxidative stress. J. Strength Cond. Res. 19, 276–285 10.1519/14823.1
    1. Booth N. E., Myhill S., McLaren-Howard J. (2012). Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Int. J. Clin. Exp. Med. 5, 208–220
    1. Brenu E. W., Johnston S., Hardcastle S. L., Huth T. K., Fuller K., Ramos S. B., et al. (2013). Immune abnormalities in patients meeting new diagnostic criteria for chronic fatigue syndrome/Myalgic Encephalomyelitis. J. Mol. Biomark. Diagn. 4, 152 10.4172/2155-9929.1000152
    1. Brenu E. W., van Driel M. L., Staines D. R., Ashton K. J., Ramos S. B., Keane J., et al. (2011). Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J. Transl. Med. 9, 81 10.1186/1479-5876-9-81
    1. Broderick G., Craddock R. C., Whistler T., Taylor R., Klimas N., Unger E. R. (2006). Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 7, 407–419 10.2217/14622416.7.3.407
    1. Broderick G., Fuite J., Kreitz A., Vernon S. D., Klimas N., Fletcher M. A. (2010). A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav. Immun. 24, 1209–1217 10.1016/j.bbi.2010.04.012
    1. Cameron B., Galbraith S., Zhang Y., Davenport T., Vollmer-Conna U., Wakefield D., et al. (2007). Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J. Infect. Dis. 196, 56–66 10.1086/518614
    1. Cambridge Cognition (1999). CANTAB. Cambridge Cognition, Cambridge
    1. Carruthers B. M., Jain A. K., de Meirleir K. L., Peterson D. L., Klimas N. G., Lerner A. M., et al. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome - clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 11, 7–115 10.1300/J092v11n01_02
    1. Carruthers B. M., van de Sande M. I., de Meirleir K. L., Klimas N. G., Broderick G., Mitchell T., et al. (2011). Myalgic Encephalomyelitis: international consensus criteria. J. Intern. Med. 270, 327–338 10.1111/j.1365-2796.2011.02428.x
    1. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., et al. (1993). Development of a fatigue scale. J. Psychosom. Res. 37, 147–153 10.1016/0022-3999(93)90081-P
    1. Chalder T., Power M. J., Wessely S. (1996). Chronic fatigue in the community: ‘a question of attribution’. Psychol. Med. 26, 791–800 10.1017/S0033291700037818
    1. Chapenko S., Krumina A., Logina I., Rasa S., Chistjakovs M., Sultanova A., et al. (2012). Association of active human herpesvirus-6, -7 and parvovirus B19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv. Virol. 2012:205085 10.1155/2012/205085
    1. Chen R., Liang F. X., Moriya J., Yamakawa J., Sumino H., Kanda T., et al. (2008). Chronic fatigue syndrome and the central nervous system. J. Int. Med. Res. 36, 867–874 10.1177/147323000803600501
    1. Chia J., Chia A., Voeller M., Lee T., Chang R. (2010). Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J. Clin. Pathol. 63, 165–168 10.1136/jcp.2009.070466
    1. Chia J. K., Chia A. (2003). Diverse etiologies for chronic fatigue syndrome. Clin. Infect. Dis. 36, 671–672 10.1086/367666
    1. Clark M. R., Katon W., Russo J., Kith P., Sintay M., Buchwald D. (1995). Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am. J. Med. 98, 187–195 10.1016/S0002-9343(99)80403-3
    1. Claypoole K. H., Noonan C., Mahurin R. K., Goldberg J., Erickson T., Buchwald D. (2007). A twin study of cognitive function in chronic fatigue syndrome: the effects of sudden illness onset. Neuropsychology 21, 507–513 10.1037/0894-4105.21.4.507
    1. Cleare A. J. (2004). The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol. Metab. 15, 55–59 10.1016/j.tem.2003.12.002
    1. Cockshell S. J., Mathias J. L. (2010). Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol. Med. 40, 1253–1267 10.1017/S0033291709992054
    1. Constant E. L., Adam S., Gillain B., Lambert M., Masquelier E., Seron X. (2011). Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls. Clin. Neurol. Neurosurg. 113, 295–302 10.1016/j.clineuro.2010.12.002
    1. Cook D. B., Lange G., DeLuca J., Natelson B. H. (2001). Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int. J. Neurosci. 107, 1–6 10.3109/00207450109149754
    1. Cook D. B., Nagelkirk P. R., Peckerman A., Poluri A., Mores J., Natelson B. H. (2005). Exercise and cognitive performance in chronic fatigue syndrome. Med. Sci. Sports Exerc. 37, 1460–1467 10.1249/01.mss.0000179921.48404.ef
    1. Davenport T. E., Stevens S. R., Baroni K., M, V. N., Snell C. R. (2011). Diagnostic accuracy of symptoms characterising chronic fatigue syndrome. Disabil. Rehabil. 33, 1768–1775 10.3109/09638288.2010.546936
    1. De Becker P., McGregor N., de Meirleir K. (2002). Possible triggers and mode of onset of chronic fatigue syndrome. J. Chronic Fatigue Syndr. 10, 3–18 10.1300/J092v10n02
    1. De Becker P., Roeykens J., Reynders M., McGregor N., de Meirleir K. (2000). Exercise capacity in chronic fatigue syndrome. Arch. Intern. Med. 160, 3270–3277 10.1001/archinte.160.21.3270
    1. Decker M. J., Tabassum H., Lin J. M., Reeves W. C. (2009). Electroencephalographic correlates of chronic fatigue syndrome. Behav. Brain Funct. 5, 43 10.1186/1744-9081-5-43
    1. De Lorenzo F., Hargreaves J., Kakkar V. V. (1997). Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clin. Auton. Res. 7, 185–190 10.1007/BF02267980
    1. DeLuca J., Christodoulou C., Diamond B. J., Rosenstein E. D., Kramer N., Natelson B. H. (2004). Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. J. Int. Neuropsychol. Soc. 10, 101–109 10.1017/S1355617704101124
    1. DeLuca J., Johnson S. K., Ellis S. P., Natelson B. H. (1997a). Sudden vs gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. J. Psychiatr. Res. 31, 83–90 10.1016/S0022-3956(96)00052-0
    1. DeLuca J., Johnson S. K., Ellis S. P., Natelson B. H. (1997b). Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J. Neurol. Neurosurg. Psychiatr. 62, 151–155 10.1136/jnnp.62.2.151
    1. DeLuca J., Johnson S. K., Natelson B. H. (1993). Information processing efficiency in chronic fatigue syndrome and multiple sclerosis. Arch. Neurol. 50, 301–304
    1. De Meirleir K. L., Khaiboullina S. F., Frémont M., Hulstaert J., Rizvanov A. A., Palotás A., et al. (2013). Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins. In Vivo 27, 177–187
    1. Demitrack M. A., Dale J. K., Straus S. E., Laue L., Listwak S. J., Kruesi M. J., et al. (1991). Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73, 1224–1234 10.1210/jcem-73-6-1224
    1. Dickson A., Toft A., O'Carroll R. E. (2009). Neuropsychological functioning, illness perception, mood and quality of life in chronic fatigue syndrome, autoimmune thyroid disease and healthy participants. Psychol. Med. 39, 1567–1576 10.1017/S0033291708004960
    1. Dowsett E. G., Ramsay A. M., McCartney R. A., Bell E. J. (1990). Myalgic encephalomyelitis - a persistent enteroviral infection? Postgrad. Med. J. 66, 526–530 10.1136/pgmj.66.777.526
    1. Dumermuth G., Lange B., Lehmann D., Meier C. A., Dinkelmann R., Molinari L. (1983). Spectral analysis of all-night sleep EEG in healthy adults. Eur. Neurol. 22, 322–339 10.1159/000115579
    1. Farquhar W. B., Hunt B. E., Taylor J. A., Darling S. E., Freeman R. (2002). Blood volume and its relation to peak O(2) consumption and physical activity in patients with chronic fatigue. Am. J. Physiol. Heart Circ. Physiol. 282, H66–H71
    1. Fisher-Wellman K., Bloomer R. J. (2009). Acute exercise and oxidative stress: a 30 year history. Dyn. Med. 8, 1 10.1186/1476-5918-8-1
    1. Fletcher M. A., Zeng X. R., Barnes Z., Levis S., Klimas N. G. (2009). Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 7, 96 10.1186/1479-5876-7-96
    1. Fluge Ø, Bruland O., Risa K., Storstein A., Kristoffersen E. K., Sapkota D., et al. (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE 6:e26358 10.1371/journal.pone.0026358
    1. Frémont M., Coomans D., Massart S., de Meirleir K. (2013). High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe 22, 50–56 10.1016/j.anaerobe.2013.06.002
    1. Friedberg F., Dechene L., McKenzie M. J., 2nd, Fontanetta R. (2000). Symptom patterns in long-duration chronic fatigue syndrome. J. Psychosom. Res. 48, 59–68 10.1016/S0022-3999(99)00077-X
    1. Fuite J., Vernon S. D., Broderick G. (2008). Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics 92, 393–399 10.1016/j.ygeno.2008.08.008
    1. Fukuda K., Straus S. E., Hickie I., Sharpe M., Dobbins J. G., Komaroff A. L. (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121, 953–959 10.7326/0003-4819-121-12-199412150-00009
    1. Fulcher K. Y., White P. D. (2000). Strength and physiological response to exercise in patients with chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatr. 69, 302–307 10.1136/jnnp.69.3.302
    1. Gaab J., Engert V., Heitz V., Schad T., Schürmeyer T. H., Ehlert U. (2004). Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J. Psychosom. Res. 56, 419–424 10.1016/S0022-3999(03)00625-1
    1. Gaab J., Hüster D., Peisen R., Engert V., Heitz V., Schad T., et al. (2002). Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom. Med. 64, 951–962 10.1097/01.PSY.0000038937.67401.61
    1. Galland B. C., Jackson P. M., Sayers R. M., Taylor B. J. (2008). A matched case control study of orthostatic intolerance in children/adolescents with chronic fatigue syndrome. Pediatr. Res. 63, 196–202 10.1203/PDR.0b013e31815ed612
    1. Gilliam A. G. (1938). Epidemiological Study on an Epidemic, Diagnosed as Poliomyelitis, Occurring Among the Personnel of Los Angeles County General Hospital During the Summer of 1934. Public Health Bulletin: 240. Washington, DC: National Institutes of Health (US)
    1. Goodwin C. (1981). Was it benign myalgic encephalomyelitis? Lancet 1, 37–38 10.1016/S0140-6736(81)90134-3
    1. Gow J. W., Hagan S., Herzyk P., Cannon C., Behan P. O., Chaudhuri A. (2009). A gene signature for post-infectious chronic fatigue syndrome. BMC Med. Genomics 2:38 10.1186/1755-8794-2-38
    1. Groeger D., O'Mahony L., Murphy E. F., Bourke J. F., Dinan T. G., Kiely B., et al. (2013). Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4, 325–339 10.4161/gmic.25487
    1. Hardcastle S. L., Brenu E. W., Johnston S., Nguyen T., Huth T., Kaur M., et al. (2014). Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). J. Clin. Cell. Immunol. 5, 190 10.4172/2155-9899.1000190
    1. He J., Hollingsworth K. G., Newton J. L., Blamire A. M. (2013). Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation. Neuroimage Clin. 2, 168–173 10.1016/j.nicl.2012.12.006
    1. Heins M. J., Knoop H., Prins J. B., Stulemeijer M., van der Meer J. W. M., Bleijenberg G. (2010). Possible detrimental effects of cognitive behaviour therapy for chronic fatigue syndrome. Psychother. Psychosom. 79, 249–256 10.1159/000315130
    1. Hilgers A., Frank J. (1996). Chronic fatigue syndrome: evaluation of a 30-criteria score and correlation with immune activation. J. Chronic Fatigue Syndr. 2, 35–47 10.1300/J092v02n04_04
    1. Hoad A., Spickett G., Elliott J., Newton J. (2008). Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM 101, 961–965 10.1093/qjmed/hcn123
    1. Holgate S. T., Komaroff A. L., Mangan D., Wessely S. (2011). Chronic fatigue syndrome: understanding a complex illness. Nat. Rev. Neurosci. 12, 539–544 10.1038/nrn3087
    1. Hollingsworth K. G., Hodgson T., Macgowan G. A., Blamire A. M., Newton J. L. (2012). Impaired cardiac function in chronic fatigue syndrome measured using magnetic resonance cardiac tagging. J. Intern. Med. 271, 264–270 10.1111/j.1365-2796.2011.02429.x
    1. Holmes G. P., Kaplan J. E., Gantz N. M., Komaroff A. L., Schonberger L. B., Straus S. E., et al. (1988). Chronic fatigue syndrome: a working case definition. Ann. Intern. Med. 108, 387–389
    1. Holtorf K. (2008). Diagnosis and treatment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction in patients with chronic fatigue syndrome (CFS) and fibromyalgia (FM). J. Chronic Fatigue Syndr. 14, 59–88 10.1300/J092v14n03_06
    1. Huibers M. J., Wessely S. (2006). The act of diagnosis: pros and cons of labelling chronic fatigue syndrome. Psychol. Med. 36, 895–900 10.1017/S0033291705006926
    1. Hurwitz B. E., Coryell V. T., Parker M., Martin P., Laperriere A., Klimas N. G., et al. (2009). Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin. Sci. 118, 125–135 10.1042/CS20090055
    1. Hutchinson C. V., Badham S. P. (2013). Patterns of abnormal visual attention in myalgic encephalomyelitis. Optom. Vis. Sci. 90, 607–614 10.1097/OPX.0b013e318294c232
    1. Hyde B. M., Goldstein J., Levine P. (eds.). (1992). The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Ottawa, ON: The Nightingale Research Foundation
    1. Iber C., Ancoli-Israel S., Chesson A., Quan S. F. (2007). The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications. 1st Edn. Westchester, IL: American Academy of Sleep Medicine
    1. Jammes Y., Steinberg J. G., Delliaux S. (2012). Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. J. Intern. Med. 272, 74–84 10.1111/j.1365-2796.2011.02488.x
    1. Jammes Y., Steinberg J. G., Delliaux S., Brégeon F. (2009). Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses. J. Intern. Med. 266, 196–206 10.1111/j.1365-2796.2009.02079.x
    1. Jason L. A., Brown A., Clyne E., Bartgis L., Evans M., Brown M. (2012b). Contrasting case definitions for chronic fatigue syndrome, myalgic encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis. Eval. Health Prof. 35, 280–304 10.1177/0163278711424281
    1. Jason L. A., Damrongvachiraphan D., Hunnell J., Bartgis L., Brown A., Evans M., et al. (2012a). Myalgic encephalomyelitis case definitions. Automatic Control Physiol. State Funct. 1:K110601 10.4303/acpsf/K110601
    1. Jason L. A., Evans M., Brown A., Brown M., Porter N., Hunnell J., et al. (2010). Sensitivity and specificity of the CDC empirical chronic fatigue syndrome case definition. Psychology 1, 9–16 10.4236/psych.2010.11002
    1. Jason L. A., Evans M., Brown M., Porter N., Brown A., Hunnell J., et al. (2011a). Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity. Disabil. Stud. Q. 31, pii: 1375.
    1. Jason L. A., Jessen T., Porter N., Boulton A., Gloria-Njoku M., Friedberg F. (2009). Examining types of fatigue among individuals with ME/CFS. Disabil. Stud. Q. 29 Available online at:
    1. Jason L. A., Sunnquist M., Brown A., Evans M., Vernon S. D., Furst J. D., et al. (2014). Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis. Fatigue. Biomed. Health Behav. 2, 40–56 10.1080/21641846.2013.862993
    1. Jason L. A., Porter N., Hunnell J., Brown A., Rademaker A., Richman J. A. (2011b). A natural history study of chronic fatigue syndrome. Rehabil. Psychol. 56, 32–42 10.1037/a0022595
    1. Jerjes W. K., Cleare A. J., Wessely S., Wood P. J., Taylor N. F. (2005). Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J. Affect. Disord. 87, 299–304 10.1016/j.jad.2005.03.013
    1. Jones D. E., Hollingsworth K. G., Jakovljevic D. G., Fattakhova G., Pairman J., Blamire A. M., et al. (2012). Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur. J. Clin. Invest. 42, 186–194 10.1111/j.1365-2362.2011.02567.x
    1. Katch V. L., Sady S. S., Freedson P. (1982). Biological variability in maximum aerobic power. Med. Sci. Sports Exerc. 14, 21–25 10.1249/00005768-198214010-00004
    1. Katz B. Z., Stewart J. M., Shiraishi Y., Mears C. J., Taylor R. (2011). Autonomic symptoms at baseline and following infectious mononucleosis in a prospective cohort of adolescents. Arch. Pediatr. Adolesc. Med. 165, 765–766 10.1001/archpediatrics.2011.124
    1. Kaushik N., Fear D., Richards S. C., McDermott C. R., Nuwaysir E. F., Kellam P., et al. (2005). Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J. Clin. Pathol. 58, 826–832 10.1136/jcp.2005.025718
    1. Kennedy G., Khan F., Hill A., Underwood C., Belch J. F. (2010). Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch. Pediatr. Adolesc. Med. 164, 817–823 10.1001/archpediatrics.2010.157
    1. Kerr J. R., Petty R., Burke B., Gough J., Fear D., Sinclair L. I., et al. (2008a). Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J. Infect. Dis. 197, 1171–1184 10.1086/533453
    1. Kerr J. R., Burke B., Petty R., Gough J., Fear D., Mattey D. L., et al. (2008b). Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. J. Clin. Pathol. 61, 730–739 10.1136/jcp.2007.053553
    1. Kindlon T. (2012). Objective compliance and outcome measures should be used in trials of exercise interventions for chronic fatigue syndrome. Eur. J. Clin. Invest. 42, 1360–1361 10.1111/j.1365-2362.2012.02724.x
    1. Kirschbaum C., Pirke K. M., Hellhammer D. H. (1993). The ‘Trier social stress test’ - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28, 76–81 10.1159/000119004
    1. Kishi A., Natelson B. H., Togo F., Struzik Z. R., Rapoport D. M., Yamamoto Y. (2011). Sleep-stage dynamics in patients with chronic fatigue syndrome with or without fibromyalgia. Sleep 34, 1551–1560 10.5665/sleep.1396
    1. Kishi A., Struzik Z. R., Natelson B. H., Togo F., Yamamoto Y. (2008). Dynamics of sleep stage transitions in healthy humans and patients with chronic fatigue syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1980–R1987 10.1152/ajpregu.00925.2007
    1. Klimas N. G., Salvato F. R., Morgan R., Fletcher M. A. (1990). Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28, 1403–1410
    1. Knoop H., Bleijenberg G., Gielissen M. F., van der Meer J. W. M., White P. D. (2007). Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? Psychother. Psychosom. 76, 171–176 10.1159/000099844
    1. Komaroff A. L. (1988). Chronic fatigue syndromes: relationship to chronic viral infections. J. Virol. Methods 21, 3–10 10.1016/0166-0934(88)90047-X
    1. Komaroff A. L. (1994). Clinical presentation and evaluation of fatigue and chronic fatigue syndrome, in Chronic Fatigue Syndrome, ed Straus S. E. (New York; Basel; Hong Kong: Marcel Dekker; ), 61–84
    1. Komaroff A. L., Fagioli L. R., Doolittle T. H., Gandek B., Gleit M. A., Guerriero R. T., et al. (1996). Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am. J. Med. 101, 281–290 10.1016/S0002-9343(96)00174-X
    1. Kovacs W. J., Ojeda S. R. (2011). Textbook of Endocrine Physiology, 6th Edn. Oxford, UK: Oxford University Press
    1. Lakhan S. E., Kirchgessner A. (2010). Gut inflammation in chronic fatigue syndrome. Nutr. Metab. 7, 79 10.1186/1743-7075-7-79
    1. LaManca J. J., Peckerman A., Walker J., Kesil W., Cook S., Taylor A., et al. (1999). Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin. Physiol. 19, 111–120 10.1046/j.1365-2281.1999.00154.x
    1. LaManca J. J., Sisto S. A., DeLuca J., Johnson S., Lange G., Pareja J., et al. (1998). Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am. J. Med. 105, 59S–65S 10.1016/S0002-9343(98)00171-5
    1. Lambert G. P. (2009). Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J. Anim. Sci. 87, E101–E108 10.2527/jas.2008-1339
    1. Lamprecht M., Frauwallner A. (2012). Exercise, intestinal barrier dysfunction and probiotic supplementation. Med. Sport Sci. 59, 47–56 10.1159/000342169
    1. Lange G., DeLuca J., Maldjian J. A., Lee H., Tiersky L. A., Natelson B. H. (1999). Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J. Neurol. Sci. 171, 3–7 10.1016/S0022-510X(99)00243-9
    1. Lange G., Steffener J., Cook D. B., Bly B. M., Christodoulou C., Liu W. C., et al. (2005). Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 26, 513–524 10.1016/j.neuroimage.2005.02.011
    1. Lawrie S. M., MacHale S. M., Cavanagh J. T., O'Carroll R. E., Goodwin G. M. (2000). The difference in patterns of motor and cognitive function in chronic fatigue syndrome and severe depressive illness. Psychol. Med. 30, 433–442 10.1017/S0033291799001816
    1. Lerner A. M., Beqaj S. H., Fitzgerald J. T., Gill K., Gill C., Edington J. (2010). Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome. Virus Adapt. Treat. 2, 47–57 10.2147/VAAT.S10695
    1. Leslie S. B. (1997). Chronic fatigue syndrome: optometric clinical presentation and management. J. Behav. Optom. 8, 155–161
    1. Lezak M. D., Howieson D. B., Loring D. W. (2004). Neuropsychological Assessment, 4th Edn. New York, NY: Oxford University Press
    1. Light A. R., Bateman L., Jo D., Hughen R. W., Vanhaitsma T. A., White A. T., et al. (2012). Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome, and fibromyalgia syndrome. J. Intern. Med. 271, 64–81 10.1111/j.1365-2796.2011.02405.x
    1. Lloyd A. R., Wakefield D., Hickie I. (1993). Immunity and the pathophysiology of chronic fatigue syndrome. Ciba Found. Symp. 173, 176–187 10.1002/9780470514382.ch11
    1. Lo C. C., Nunes Amaral L. A., Havlin S., Ivanov C., Penzel T., Peter J. H., et al. (2002). Dynamics of sleep-wake transitions during sleep. Europhys. Lett. 57, 625–631 10.1209/epl/i2002-00508-7
    1. Lorusso L., Mikhaylova S. V., Capelli E., Ferrari D., Ngonga G. K., Ricevuti G. (2009). Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 8, 287–291 10.1016/j.autrev.2008.08.003
    1. Lutgendorf S., Klimas N. G., Antoni M., Brickman A., Fletcher M. A. (1995). Relationships of cognitive difficulties to immune measures, depression and illness burden in chronic fatigue syndrome. J. Chronic Fatigue Syndr. 1, 23–41 10.1300/J092v01n02_03
    1. MacHale S. M., Cavanagh J. T., Bennie J., Carroll S., Goodwin G. M., Lawrie S. M. (1998). Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 38, 213–217 10.1159/000026543
    1. Maes M., Mihaylova I., Kubera M., Bosmans E. (2007b). Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro Endocrinol. Lett. 28, 463–469
    1. Maes M., Mihaylova I., Leunis J. C. (2007a). Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J. Affect. Disord. 99, 237–240 10.1016/j.jad.2006.08.021
    1. Maes M., Twisk F. N. M. (2010). Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med. 8:35 10.1186/1741-7015-8-35
    1. Maes M., Twisk F. N. M., Johnson C. (2012a). Myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and chronic fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res. 200, 754–760 10.1016/j.psychres.2012.03.031
    1. Maes M., Twisk F. N. M., Kubera M., Ringel K. (2012b). Evidence for inflammation and activation of cell-mediated immunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. J. Affect. Disord. 136, 933–939 10.1016/j.jad.2011.09.004
    1. Maes M., Twisk F. N. M., Kubera M., Ringel K., Leunis J. C., Geffard M. (2012c). Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. J. Affect. Disord. 136, 909–917 10.1016/j.jad.2011.09.010
    1. Mathew S. J., Mao X., Keegan K. A., Levine S. M., Smith E. L., Heier L. A., et al. (2009). Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study. NMR Biomed. 22, 251–258 10.1002/nbm.1315
    1. McCully K. K., Natelson B. H. (1999). Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin. Sci. 97, 603–608 10.1042/CS19980372
    1. McHorney C. A., Ware J. E., Jr., Raczek A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31, 247–263 10.1097/00005650-199303000-00006
    1. Meeus M., Mistiaen W., Lambrecht L., Nijs J. (2009). Immunological similarities between cancer and chronic fatigue syndrome: the common link to fatigue? Anticancer Res. 29, 4717–4726
    1. Meeus M., Nijs J., Hermans L., Goubert D., Calders P. (2013). The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin. Ther. Targets 17, 1081–1089 10.1517/14728222.2013.818657
    1. Melmed S., Polonsky K. S. P., Larsen R. M. D., Kronenberg H. M. (2011). Williams Textbook of Endocrinology, 12th Edn. Philadelphia, PA: Elsevier/Saunders
    1. Millard A. L., Valli P. V., Stussi G., Mueller N. J., Yung G. P., Seebach J. D. (2013). Brief exercise increases peripheral blood NK cell counts without immediate functional changes, but impairs their responses to ex vivo stimulation. Front. Immunol. 4:125 10.3389/fimmu.2013.00125
    1. Miwa K., Fujita M. (2009). Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and “small heart”. J. Cardiol. 54, 29–35 10.1016/j.jjcc.2009.02.008
    1. Miwa K., Fujita M. (2011). Small heart with low cardiac output for orthostatic intolerance in patients with chronic fatigue syndrome. Clin. Cardiol. 34, 782–786 10.1002/clc.20962
    1. Mogharnas M., Gaeini A. A., Sheikholeslami Vatani D., Faraji H. (2011). Effects of aerobic and anaerobic training on inflammatory markers in rats. Med. Sport 64, 21–30
    1. Montoya J. G., Kogelnik A. M., Bhangoo M., Lunn M. R., Flamand L., Merrihew L. E., et al. (2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J. Med. Virol. 85, 2101–2109 10.1002/jmv.23713
    1. Myhill S., Booth N. E., McLaren-Howard J. (2009). Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2, 1–16
    1. Nacul L. C., Lacerda E. M., Pheby D., Campion P., Molokhia M., Fayyaz S., et al. (2011). Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 9:91 10.1186/1741-7015-9-91
    1. Natelson B. H. (2013). Brain dysfunction as one cause of CFS symptoms including difficulty with attention and concentration. Front. Physiol. 4:109 10.3389/fphys.2013.00109
    1. Natelson B. H., Weaver S. A., Tseng C. L., Ottenweller J. E. (2005). Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 12, 52–55 10.1128/CDLI.12.1.52-55.2005
    1. Newton J. L., Okonkwo O., Sutcliffe K., Seth A., Shin J., Jones D. E. (2007). Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 100, 519–526 10.1093/qjmed/hcm057
    1. Nicolson G. L., Gan R., Haier J. (2003). Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS 111, 557–566 10.1034/j.1600-0463.2003.1110504.x
    1. Ocon A. J. (2013). Caught in the thickness of brain fog: exploring the cognitive symptoms of chronic fatigue syndrome. Front. Physiol. 4:63 10.3389/fphys.2013.00063
    1. Ocon A. J., Messer Z., Medow M., Stewart J. (2012). Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome. Clin. Sci. 122, 227–238 10.1042/CS20110241
    1. Papadopoulos A. S., Cleare A. J. (2011). Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat. Rev. Endocrinol. 8, 22–32 10.1038/nrendo.2011.153
    1. Parker A. J., Wessely S., Cleare A. J. (2001). The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med. 31, 1331–1345 10.1017/S0033291701004664
    1. Patarca R., Klimas N. G., Garcia M. N., Walters M. J., Dombroski D., Pons H., et al. (1995). Dysregulated expression of soluble immune mediator receptors in a subset of patients with chronic fatigue syndrome: cross-sectional categorization of patients by immune status. J. Chronic Fatigue Syndr. 1, 79–94 10.1300/J092v01n01_06
    1. Patrick Neary J., Roberts A. D., Leavins N., Harrison M. F., Croll J. C., Sexsmith J. R. (2008). Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome. Clin. Physiol. Funct. Imaging 28, 364–372 10.1111/j.1475-097X.2008.00822.x
    1. Paul L., Wood L., Behan W. M., Maclaren W. M. (1999). Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. Eur. J. Neurol. 6, 63–69 10.1046/j.1468-1331.1999.610063.x
    1. Peckerman A., LaManca J. J., Dahl K. A., Chemitiganti R., Qureishi B., Natelson B. H. (2003). Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am. J. Med. Sci. 326, 55–60 10.1097/00000441-200308000-00001
    1. Pietrangelo T., Mancinelli R., Toniolo L., Toniolo L., Vecchiet J., Fanò G., et al. (2009). Transcription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome. Int. J. Immunopathol. Pharmacol. 22, 795–807
    1. Porter N., Lerch A., Jason L. A., Sorenson M., Fletcher M. A., Herrington J. (2010). A comparison of immune functionality in viral versus non-viral CFS subtypes. J. Behav. Neurosci. Res. 8, 1–8
    1. Puri B. K., Jakeman P. M., Agour M., Gunatilake K. D., Fernando K. A., Gurusinghe A. I., et al. (2012). Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study. Br. J. Radiol. 85, e270–e273 10.1259/bjr/93889091
    1. Quistorff B., Secher N. H., van Lieshout J. J. (2008). Lactate fuels the human brain during exercise. FASEB J. 22, 3443–3449 10.1096/fj.08-106104
    1. Ramsay A. M. (1988). Myalgic Encephalomyelitis and Postviral Fatigue States: the Saga of Royal Free Disease. London: Gower Medical Publishing
    1. Ray C., Jefferies S., Weir W. R. (1997). Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. J. Psychosom. Res. 43, 405–415 10.1016/S0022-3999(97)00111-6
    1. Rechtschaffen A., Kales A. (1968). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep States of Human Subjects. Washington, DC: US Government Printing Office
    1. Reeves W. C., Wagner D., Nisenbaum R., Jones J. F., Gurbaxani B., Solomon L., et al. (2005). Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med. 3:19 10.1186/1741-7015-3-19
    1. Reyes M., Dobbins J. G., Nisenbaum R., Subedar N., Randall B., Reeves W. C. (1998). Chronic fatigue syndrome progression and self-defined recovery: evidence from the CDC surveillance system. J. Chronic Fatigue Syndr. 5, 17–27 10.1300/J092v05n01_03
    1. Roelant C., de Meirleir K. (2012). Self-test monitoring of the Th1/Th2 balance in health and disease with special emphasis on chronic fatigue syndrome/myalgic encephalomyelitis. JMLD 3, 1–6 10.5897/JMLD11.023
    1. Rommelse N. N., Van der Stigchel S., Sergeant J. A. (2008). A review on eye movement studies in childhood and adolescent psychiatry. Brain Cogn. 68, 391–414 10.1016/j.bandc.2008.08.025
    1. Rowe P. C., Bou-Holaigah I., Kan J. S., Calkins H. (1995). Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 345, 623–624 10.1016/S0140-6736(95)90525-1
    1. Sakharov D. A., Maltseva D. V., Riabenko E. A., Shkurnikov M. U., Northoff H., Tonevitsky A. G., et al. (2012). Passing the anaerobic threshold is associated with substantial changes in the gene expression profile in white blood cells. Eur. J. Appl. Physiol. 112, 963–972 10.1007/s00421-011-2048-3
    1. Schutzer S. E., Angel T. E., Liu T., Schepmoes A. A., Clauss T. R., Adkins J. A., et al. (2011). Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE 6:e17287 10.1371/journal.pone.0017287
    1. Scott L. V., Medbak S., Dinan T. G. (1998). The low dose ACTH test in chronic fatigue syndrome and in health. Clin. Endocrinol. (Oxf). 48, 733–737 10.1046/j.1365-2265.1998.00418.x
    1. Scott L. V., Teh J., Reznek R., Martin A., Sohaib A., Dinan T. G. (1999). Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 24, 759–768 10.1016/S0306-4530(99)00028-1
    1. Sharpe M. C., Archard L. C., Banatvala J. E., Borysiewicz L. K., Clare A. W., David A., et al. (1991). Chronic fatigue syndrome: guidelines for research. J. R. Soc. Med. 84, 118–121
    1. Sheedy J. R., Wettenhall R. E., Scanlon D., Gooley P. R., Lewis D. P., McGregor N., et al. (2009). Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo 23, 621–628
    1. Shungu D. C., Weiduschat N., Murrough J. W., Mao X., Pillemer S., Dyke J. P., et al. (2012). Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 25, 1073–1087 10.1002/nbm.2772
    1. Siegel S. D., Antoni M. H., Fletcher M. A., Maher K., Segota M. C., Klimas N. (2006). Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup. J. Psychosom. Res. 60, 559–566 10.1016/j.jpsychores.2006.03.001
    1. Siemionow V., Fang Y., Calabrese L., Sahgal V., Yue G. H. (2004). Altered central nervous system signal during motor performance in chronic fatigue syndrome. Clin. Neurophysiol. 115, 2372–2381 10.1016/j.clinph.2004.05.012
    1. Smylie A. L., Broderick G., Fernandes H., Razdan S., Barnes Z., Collado F., et al. (2013). A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome. BMC Immunol. 14:29 10.1186/1471-2172-14-29
    1. Snell C. R., Stevens S. R., Davenport T. E., VanNess J. M. (2013). Discriminative validity of metabolic and workload measurements to identify individuals with chronic fatigue syndrome. Phys. Ther. 93, 1484–1492 10.2522/ptj.20110368
    1. Stark T., Walker B., Phillips J. K., Fejer R., Beck R. (2011). Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. PM R 3, 472–479 10.1016/j.pmrj.2010.10.025
    1. Steensberg A., Toft A. D., Bruunsgaard H., Sandmand M., Halkjaer-Kristensen J., Pedersen B. K. (2001). Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J. Appl. Physiol. 91, 1708–1712
    1. Stewart J. M., Gewitz M. H., Weldon A., Arlievsky N., Li K., Munoz J. (1999). Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 103, 116–121 10.1542/peds.103.1.116
    1. Strauss E., Sherman E. M. S., Spreen O. (2006). A Compendium of Neuropsychological Tests, 3rd Edn. New York: Oxford University Press
    1. Streeten D. H. (1987). Orthostatic Disorders of the Circulation: Mechanisms, Manifestations and Treatment. New York, NY: Plenum Medical Book Publishing
    1. Streeten D. H., Anderson G. H. J. (1998). The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin. Auton. Res. 8, 119–124 10.1007/BF02267822
    1. Streeten D. H., Bell D. S. (1998). Circulating blood volume in chronic fatigue syndrome. J. Chronic Fatigue Syndr. 4, 3–11 10.1300/J092v04n01_02
    1. Suárez A., Guillamo E., Roig T., Blázquez A., Alegre J., Bermúdez J., et al. (2010). Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J. Womens. Health (Larchmt). 19, 1073–1077 10.1089/jwh.2008.1255
    1. Tak L. M., Cleare A. J., Ormel J., Manoharan A., Kok I. C., Wessely S., et al. (2011). Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol. Psychol. 87, 183–194 10.1016/j.biopsycho.2011.02.002
    1. Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS). (2009). Guidelines for the diagnosis and management of syncope (version 2009). Eur. Heart J. 30, 2631–2671 10.1093/eurheartj/ehp298
    1. Thambirajah A. A., Sleigh K., Stiver H. G., Chow A. W. (2008). Differential heat shock protein responses to strenuous standardized exercise in chronic fatigue syndrome patients and matched healthy controls. Clin. Invest. Med. 31, E319–E327
    1. The Medical Staff of The Royal Free Hospital. (1957). An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in 1955. Br. Med. J. 2, 895–904 10.1136/bmj.2.5050.895
    1. Thomas M., Smith A. (2009). An investigation into the cognitive deficits associated with chronic fatigue syndrome. Open Neurol. J. 3, 13–23 10.2174/1874205X00903010013
    1. Tiersky L. A., Johnson S. K., Lange G., Natelson B. H., DeLuca J. (1997). Neuropsychology of chronic fatigue syndrome: a critical review. J. Clin. Exp. Neuropsychol. 19, 560–586 10.1080/01688639708403744
    1. Tomic S., Brkic S., Maric D., Mikic A. N. (2012). Lipid and protein oxidation in female patients with chronic fatigue syndrome. Arch. Med. Sci. 8, 886–891 10.5114/aoms.2012.31620
    1. Torres-Harding S., Sorenson M., Jason L., Maher K., Fletcher M. A., Reynolds N., et al. (2008). The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. J. Appl. Biobehav. Res. 13, 157–180 10.1111/j.1751-9861.2008.00033.x
    1. Twisk F. N. M., Arnoldus R. J. W. (2012). Graded exercise therapy (GET)/cognitive behavioural therapy (CBT) is often counterproductive in myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS). Eur. J. Clin. Invest. 42, 1255–1256 10.1111/j.13652362.2012.02718.x
    1. Twisk F. N. M., Arnoldus R. J. W. (2013). Comment and reply on: ME is a distinct diagnostic entity, not part of a chronic fatigue spectrum. Expert Opin. Med. Diagn. 7, 413–415 10.1517/17530059.2013.795147
    1. Van der Meer J. W. M., Lloyd A. R. (2012). A controversial consensus - Comment on article by Broderick et al. J. Intern. Med. 271, 29–31 10.1111/j.1365-2796.2011.02468.x
    1. Van der Ploeg R. J. O., Fidler V., Oosterhuis H. J. G. H. (1991). Hand-held myometry: reference values. J. Neurol. Neurosurg. Psychiatr. 54, 244–247
    1. Van der Werf S. P., de Vree B., Alberts M., van der Meer J. W. M., Bleijenberg G. (2002). Netherlands Fatigue Research Group Nijmegen. Natural course and predicting self-reported improvement in patients with chronic fatigue syndrome with a relatively short illness duration. J. Psychosom. Res. 53, 749–753 10.1016/S0022-3999(02)00324-0
    1. VanNess J. M., Snell C. R., Stevens S. R., Bateman L., Keller B. A. (2006). Using serial cardiopulmonary exercise tests to support a diagnosis of chronic fatigue syndrome. Med. Sci. Sports Exerc. 38, S85 10.1249/00005768-200605001-00386
    1. VanNess J. M., Snell C. R., Stevens S. R., Stiles T. L. (2007). Metabolic and neurocognitive responses to an exercise challenge in chronic fatigue syndrome (CFS). Med. Sci. Sports Exerc. 39, S445 10.1249/01.mss.0000274760.28522.df
    1. Vedelago L. J. (1997). Visual dysfunction in chronic fatigue syndrome: behavioural optometric assessment and management. J. Behav. Optom. 8, 149–154
    1. Vercoulen J. H. M. M., Swanink C. M. A., Fennis J. F. M., Galama J. M. D., van der Meer J. W. M., Bleijenberg G. (1994). Dimensional assessment of chronic fatigue syndrome. J. Psychosom. Res. 38, 383–392 10.1016/0022-3999(94)90099-X
    1. Vermeulen R. C., Vermeulen van Eck I. W. (2014). Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome. J. Transl. Med. 12, 20 10.1186/1479-5876-12-20
    1. Vermeulen R. C. W., Kurk R. M., Visser F. C., Sluiter W., Scholte H. R. (2010). Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J. Transl. Med. 8, 93 10.1186/1479-5876-8-93
    1. Wang C. Y., Olson S. L., Protas E. J. (2002). Test-retest strength reliability: hand-held dynamometry in community-dwelling elderly fallers. Arch. Phys. Med. Rehabil. 83, 811–815 10.1053/apmr.2002.32743
    1. Ware J. E., Jr., Sherbourne C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473–483 10.1097/00005650-199206000-00002
    1. Watson W. S., McCreath G. T., Chaudhuri A., Behan P. O. (1997). Possible cell membrane transport defect in chronic fatigue syndrome? J. Chronic Fatigue Syndr. 3, 1–13 10.1300/J092v03n03_01
    1. Watt T., Oberfoell S., Balise R., Lunn M. R., Kar A. K., Merrihew L., et al. (2012). Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers. J. Med. Virol. 84, 1967–1974 10.1002/jmv.23411
    1. Wechsler D. (1981). Wechsler Adult Intelligence Scale-revised. San Antonio, TX: The Psychological Corporation
    1. Weinstein A. A., Drinkard B. M., Diao G., Furst G., Dale J. K., Straus S. E., et al. (2009). Exploratory analysis of the relationships between aerobic capacity and self-reported fatigue in patients with rheumatoid arthritis, polymyositis, and chronic fatigue syndrome. PM R 1, 620–628 10.1016/j.pmrj.2009.04.007
    1. Whistler T., Jones J. F., Unger E. R., Vernon S. D. (2005). Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol. 5:5 10.1186/1472-6793-5-5
    1. Whistler T., Unger E. R., Nisenbaum R., Vernon S. D. (2003). Integration of gene expression, clinical, and epidemiologic data to characterize chronic fatigue syndrome. J. Transl. Med. 1, 10 10.1186/1479-5876-1-10
    1. White A. T., Light A. R., Hughen R. W., Bateman L., Martins T. B., Hill H. R., et al. (2010). Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology 47, 615–624 10.1111/j.1469-8986.2010.00978.x
    1. White A. T., Light A. R., Hughen R. W., Vanhaitsma T. A., Light K. C. (2012). Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosom. Med. 74, 46–54 10.1097/PSY.0b013e31824152ed
    1. White P. D., Goldsmith K. A., Johnson A. L., Potts L., Walwyn R., DeCesare J. C., et al. (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 377, 823–836 10.1016/S0140-6736(11)60096-2
    1. WHO. (1967). International Classification of Diseases. Eighth Revision I (code 323), Geneva, IL: World Health Organization
    1. WHO. (1992). International Classification of Diseases. Tenth Revision (code G93.3), Geneva, IL: World Health Organization
    1. Wilson A., Hickie I., Hadzi-Pavlovic D., Wakefield D., Parker G., Straus S. E., et al. (2001). What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust. N.Z. J. Psychiatry 35, 520–527 10.1046/j.1440-1614.2001.00888.x
    1. Wyller V. B., Due R., Saul J. P., Amlie J. P., Thaulow E. (2007). Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls. Am. J. Cardiol. 99, 997–1001 10.1016/j.amjcard.2006.10.067
    1. Yoshiuchi K., Farkas J., Natelson B. H. (2006). Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin. Physiol. Funct. Imaging 26, 83–86 10.1111/j.1475-097X.2006.00649.x
    1. Zhang C., Baumer A., Mackay I. R., Linnane A. W., Nagley P. (1995). Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome. Hum. Mol. Genet. 4, 751–754 10.1093/hmg/4.4.751
    1. Zhang L., Gough J., Christmas D., Mattey D. L., Richards S. C., Main J., et al. (2010). Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J. Clin. Pathol. 63, 156–164 10.1136/jcp.2009.072561

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다